Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
-

About FDA

  • Share Share this page
-

Office of Critical Path Programs

The Critical Path Initiative (CPI) is FDA's national strategy for transforming the way FDA-regulated products are developed, evaluated, manufactured, and used.

-

About Critical Path

-
 

Contact Us

  • FDA's Office of Critical Path Programs

  • 301-827-1512
  • 301-443-9718

    • Dr. Rachel Behrman, Director

    Dr. Leonard Sacks, Deputy Director

-
-
-
-
-
-